BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24530099)

  • 1. The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): a novel therapeutic target for eosinophilic disorders.
    Legrand F; Tomasevic N; Simakova O; Lee CC; Wang Z; Raffeld M; Makiya MA; Palath V; Leung J; Baer M; Yarranton G; Maric I; Bebbington C; Klion AD
    J Allergy Clin Immunol; 2014 May; 133(5):1439-47, 1447.e1-8. PubMed ID: 24530099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
    Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
    J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMR1, the human homolog of F4/80, is an eosinophil-specific receptor.
    Hamann J; Koning N; Pouwels W; Ulfman LH; van Eijk M; Stacey M; Lin HH; Gordon S; Kwakkenbos MJ
    Eur J Immunol; 2007 Oct; 37(10):2797-802. PubMed ID: 17823986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADGRE1 (EMR1, F4/80) Is a Rapidly-Evolving Gene Expressed in Mammalian Monocyte-Macrophages.
    Waddell LA; Lefevre L; Bush SJ; Raper A; Young R; Lisowski ZM; McCulloch MEB; Muriuki C; Sauter KA; Clark EL; Irvine KM; Pridans C; Hope JC; Hume DA
    Front Immunol; 2018; 9():2246. PubMed ID: 30327653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
    Heinisch IV; Bizer C; Volgger W; Simon HU
    J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siglec-7 on peripheral blood eosinophils: Surface expression and function.
    Legrand F; Landolina N; Zaffran I; Emeh RO; Chen E; Klion AD; Levi-Schaffer F
    Allergy; 2019 Jul; 74(7):1257-1265. PubMed ID: 30690753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases.
    Schmid-Grendelmeier P; Altznauer F; Fischer B; Bizer C; Straumann A; Menz G; Blaser K; Wüthrich B; Simon HU
    J Immunol; 2002 Jul; 169(2):1021-7. PubMed ID: 12097410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of an anti-eosinophil monoclonal antibody that recognizes granulocytes from patients with blood eosinophilia but not from subjects without eosinophilia.
    Ochiai K; Iwamoto I; Takahashi H; Yoshida S; Nakagawa N; Tomioka H; Yoshida S
    Clin Exp Immunol; 1991 May; 84(2):283-8. PubMed ID: 2025954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome.
    Caldwell JM; Collins MH; Stucke EM; Putnam PE; Franciosi JP; Kushner JP; Abonia JP; Rothenberg ME
    J Allergy Clin Immunol; 2014 Nov; 134(5):1114-24. PubMed ID: 25234644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Modeling of Eosinophil-Associated Diseases.
    Upparahalli Venkateshaiah S; Manohar M; Kandikattu HK; Mishra A
    Methods Mol Biol; 2021; 2241():275-291. PubMed ID: 33486743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.
    Kim YJ; Prussin C; Martin B; Law MA; Haverty TP; Nutman TB; Klion AD
    J Allergy Clin Immunol; 2004 Dec; 114(6):1449-55. PubMed ID: 15577851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis.
    Wilson TM; Maric I; Shukla J; Brown M; Santos C; Simakova O; Khoury P; Fay MP; Kozhich A; Kolbeck R; Metcalfe DD; Klion AD
    J Allergy Clin Immunol; 2011 Nov; 128(5):1086-92.e1-3. PubMed ID: 21762978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Neutralization of the Eosinophil Peroxidase Antibody Accelerates Eosinophilic Mucin Decomposition.
    Kobayashi Y; Chu HH; Bui DV; Yun Y; Nguyen LM; Mitani A; Suzuki K; Asako M; Kanda A; Iwai H
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels.
    Stein ML; Villanueva JM; Buckmeier BK; Yamada Y; Filipovich AH; Assa'ad AH; Rothenberg ME
    J Allergy Clin Immunol; 2008 Jun; 121(6):1473-83, 1483.e1-4. PubMed ID: 18410960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis.
    Kataoka N; Satoh T; Hirai A; Saeki K; Yokozeki H
    Immunology; 2013 Sep; 140(1):78-86. PubMed ID: 23582181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease.
    Kuang FL; De Melo MS; Makiya M; Kumar S; Brown T; Wetzler L; Ware JM; Khoury P; Collins MH; Quezado M; Pittaluga S; Klion AD
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1598-1605.e2. PubMed ID: 35283330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An anti-human eosinophil monoclonal antibody AE500 that reacts only with granulocytes from hypereosinophilic patients].
    Ochiai K; Iwamoto I; Kimura A; Nakagawa N; Tomioka H; Yoshida S; Takahashi H; Yoshida A
    Arerugi; 1990 May; 39(5):459-64. PubMed ID: 2393351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis.
    Bullock JZ; Villanueva JM; Blanchard C; Filipovich AH; Putnam PE; Collins MH; Risma KA; Akers RM; Kirby CL; Buckmeier BK; Assa'ad AH; Hogan SP; Rothenberg ME
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):22-31. PubMed ID: 17592361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome.
    Tajima K; Katagiri T
    Dig Dis Sci; 1996 Feb; 41(2):282-8. PubMed ID: 8601370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.
    Stein ML; Collins MH; Villanueva JM; Kushner JP; Putnam PE; Buckmeier BK; Filipovich AH; Assa'ad AH; Rothenberg ME
    J Allergy Clin Immunol; 2006 Dec; 118(6):1312-9. PubMed ID: 17157662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.